Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesNov 29, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 23, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 22, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 18, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 14, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 9, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 31, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 19, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 4, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 29, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 19, 2016View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Sep 1, 2016View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Sep 1, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 30, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 17, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 3, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 3, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 3, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 28, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 26, 2016View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 20, 2016View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Jul 19, 2016View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-103

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information